MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0161159
Medmark Pharmaceuticals Private Limited
Medmark Pharmaceuticals Private Limited - pharma in Kalyan, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹5.29 Lakh
▼ 74% YoY
Net loss · FY 2025
₹1.13 Lakh
Net margin -21.4%
EBITDA · FY 2025
-₹44,332
EBITDA margin -8.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹8.98 Lakh
Secured borrowings
Company age
14 yrs
Est. 2012
Directors on board
2
As per MCA filings
About Medmark Pharmaceuticals Private Limited
Data last updated:
Medmark Pharmaceuticals Private Limited is a private limited company based in Kalyan, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 June 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33119MH2012PTC231810. Its GSTIN is 27AAHCM9811F1ZC (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gyanesh Shivnarayan Singh and Anita Gyanesh Singh.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kalyan, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.29 Lakh, a decline of 74% compared to the previous year. For the same year it recorded a net loss of ₹1.13 Lakh (net margin -21.4%) and EBITDA of -₹44,332 (EBITDA margin -8.4%). Revenue has declined at a compounded annual rate (CAGR) of 39% over three years and 20% over five years.
As per MCA filings, the company has open charges of ₹8.98 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it.
Medmark Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0161159). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U33119MH2012PTC231810
Registration Number 231810
Incorporation Date 04 June 2012
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0161159
Recognitions & Rankings of Medmark Pharmaceuticals
Contact details
Medmark Pharmaceuticals Private Limited's registered office is in Kalyan, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressShop No.06 Bappa Maurya Building, Madhala Pada, Kalyan, Maharashtra, India – 421201
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Medmark Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Medmark Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Medmark Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medmark Pharmaceuticals Private Limited, buy the company report.
Financials of Medmark Pharmaceuticals Private Limited
FY 2025 filings availableMedmark Pharmaceuticals Private Limited reported revenue of ₹5.29 Lakh (down 74% YoY) for FY 2025.
Revenue · FY 2025
₹5.29 Lakh ▼ 74%
Net loss · FY 2025
₹1.13 Lakh margin -21.4%
EBITDA · FY 2025
-₹44,332 margin -8.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 74%
3 years · compounded
▼ 39%
5 years · compounded
▼ 20%
EBITDA CAGR growth
1 year
▲ 73%
3 years · compounded
▼ 43%
5 years · compounded
▼ 26%
Revenue has declined at a compounded annual rate (CAGR) of 20% over five years, including a 74% fall in the latest year. EBITDA rose 73% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹44,332 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.13 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -8.4% | ||||
| Net Profit Margin | -21.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medmark Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medmark Pharmaceuticals Private Limited
Medmark Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gyanesh Shivnarayan Singh | Director | 04 Jun 2012 | 14 Years 5 Months | Current |
| Anita Gyanesh Singh | Director | 04 Jun 2012 | 14 Years 5 Months | Current |
Peer comparison
Medmark Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Palvik Pharmaceuticals Private Limited | ₹5.32 Lakh (FY 2017) | 19.0% | Delhi, India | |||
| Medmark Pharmaceuticals Private Limitedthis company | ₹5.29 Lakh (FY 2025) | -₹1.13 Lakh | -21.4% | -74.0% | Kalyan, Maharashtra, India | |
| Ryzil Pharmaceuticals Private Limited | ₹5.28 Lakh (FY 2018) | Moradabad, Uttar Pradesh, India | ||||
| Starcia Pharmaceuticals Private Limited | ₹5.25 Lakh (FY 2025) | -21.0% | Surat, Gujarat, India |
To see the full peer comparison of Medmark Pharmaceuticals Private Limited, buy the company report.
Auditor
Medmark Pharmaceuticals Private Limited is audited by MANOJ JAISWAL & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANOJ JAISWAL & CO | FY 2022 | 142257W |
Shareholding
The shareholding of Medmark Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medmark Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹8.98 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Jul 2020 | 100348045 | Idbi Bank Limited | ₹98,000 | Open | |
| 29 Jul 2015 | 10600046 | Idbi Bank Limited | ₹8 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
Medmark Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Total cases
2
Filed against the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North, Delhi | Execution petition | Filed against the company by Menamed Pharma Private Limited | Disposed |
| District court, North, Delhi | Court case (CS (COMM.)) | Filed against the company by Menamed Pharma Private Limited | Disposed |
To see the full case history of Medmark Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medmark Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medmark Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCM9811F1ZC | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medmark Pharmaceuticals Private Limited, buy the company report.
Recent activity
Medmark Pharmaceuticals Private Limited has 2 board changes on record since 2012: 2 appointments. The latest: Anita Gyanesh Singh was appointed as Director on 04 Jun 2012.
AGM
Medmark Pharmaceuticals Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Filing
Medmark Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge with Idbi Bank Limited amounted to Rs. 0.98 Lakh with Charge ID 100348045 was registered on 06 Jul 2020.
Charges
A charge with Idbi Bank Limited amounted to Rs. 8.00 Lakh with Charge ID 10600046 was registered on 29 Jul 2015.
Appointed
Anita Gyanesh Singh was appointed as Director.
Appointed
Gyanesh Shivnarayan Singh was appointed as Director.
Incorporation
04 Jun 2012
Medmark Pharmaceuticals Private Limited was registered on 04 Jun 2012 with Roc Mumbai Ii & aged 14 years 5 months as per MCA records.
Frequently asked questions
Medmark Pharmaceuticals is an active private limited company based in Kalyan, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 June 2012 (14+ years old) and is registered under CIN U33119MH2012PTC231810.
Medmark Pharmaceuticals has 2 current directors:
- Gyanesh Shivnarayan Singh - Director
- Anita Gyanesh Singh - Director
The latest financial statements of Medmark Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Medmark Pharmaceuticals is 27AAHCM9811F1ZC, registered in Maharashtra.
The CIN (Corporate Identification Number) of Medmark Pharmaceuticals is U33119MH2012PTC231810. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medmark Pharmaceuticals has 2 court cases on record: 2 filed against it.
Medmark Pharmaceuticals was incorporated on 04 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Medmark Pharmaceuticals by revenue are Palvik Pharmaceuticals Private Limited, Ryzil Pharmaceuticals Private Limited, Starcia Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Anita Gyanesh Singh was appointed as Director on 04 Jun 2012. Gyanesh Shivnarayan Singh was appointed as Director on 04 Jun 2012.
Yes, Medmark Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0161159).
The registered office of Medmark Pharmaceuticals is at Shop No.06 Bappa Maurya Building, Madhala Pada, Kalyan, Maharashtra, India – 421201.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages